How to Document Bipolar Disorder Treatment and Mood Episode Tracking

Bipolar disorder is not one thing that presents the same way in every session. It is a spectrum of mood dysregulation that cycles across distinct episode types, fluctuates in severity and duration, and is shaped by medication, sleep, stress, and the individual's own illness awareness. A therapist or prescriber who sees a client with bipolar I disorder on a calm Thursday in June may see a fundamentally different clinical presentation than the one documented in a hospitalization note from the prior January.

This is precisely why documentation in bipolar disorder treatment requires more structure, more longitudinal tracking, and more clinical specificity than documentation for many other conditions. A note that reads "mood stable, continued treatment" tells you almost nothing useful about where this client sits in their illness course. A note that captures current episode status, functional impairment level, safety indicators, medication response, and the client's own illness insight gives you something you can actually build on.

This guide covers what to document across the bipolar disorder spectrum, how to track mood episodes longitudinally, how to approach safety documentation during manic and hypomanic states, and how to coordinate records between therapists and prescribers. The guidance applies to clinicians treating bipolar I, bipolar II disorder, and cyclothymic disorder (cyclothymia), with attention to where the documentation requirements differ.

Why Bipolar Disorder Documentation Has Unique Challenges

Most outpatient mental health documentation assumes relative stability. The client comes in each week, describes what happened between sessions, and the clinician documents presenting concerns, interventions, and response. The forward-looking plan is usually a variation of the previous one.

Bipolar disorder disrupts this model in several ways.

Episode state changes the clinical task. A session during a depressive episode and a session during a hypomanic episode may both appear in the same client's chart, but the clinical goals, safety considerations, and documentation priorities are entirely different. The note for each should reflect the episode context, not just the content of what was discussed.

Mood state is not always self-reported reliably. Clients experiencing hypomania often do not identify it as such. They feel good. They are sleeping less but feel energized. They may be dismissive of clinical concern. Documentation needs to capture what the clinician observed, not only what the client endorsed.

Longitudinal pattern recognition requires longitudinal data. Identifying rapid cycling (four or more mood episodes within a twelve-month period), mixed features, or a shift from bipolar II to a more severe presentation requires comparing today's note with notes from six, twelve, or eighteen months ago. If those earlier notes do not specify episode type, duration, severity, and functional impact, the pattern is invisible in the chart.

Medication changes are clinical events. When a prescriber adjusts a mood stabilizer or adds an atypical antipsychotic, that decision needs to be documented in context. A note that names the medication change but does not record the clinical rationale (what symptoms drove the change, what target symptoms are being addressed, what baseline is being compared against) leaves the record incomplete.

Establishing the Episode Baseline

Every bipolar treatment chart should have a clearly documented episode history as part of the initial assessment or treatment plan. This is not a one-time task that gets buried in the intake and never referenced again. It is the baseline against which every subsequent note is measured.

The episode baseline should capture:

• Diagnosis subtype with the basis for distinction clearly stated. Bipolar I requires at least one full manic episode. Bipolar II requires at least one hypomanic episode and at least one major depressive episode, with no history of full mania. Cyclothymia requires at least two years of subsyndromal hypomanic and depressive periods that do not meet full episode criteria. Documenting which subtype you are treating, and why, is clinically and legally significant.
• Age of onset and first episode type. This contextualizes the illness course.
• Number and type of prior episodes. "Has had three depressive episodes and two hypomanic episodes over seven years" is more useful than "history of bipolar disorder."
• Prior hospitalization history with approximate dates and precipitants if known.
• Cycle frequency and pattern. Does this client's illness tend toward prolonged depression with brief hypomanic periods, or do they rapid-cycle? Are episodes linked to seasons?
• Highest severity ever reached. A client whose bipolar II has never involved psychosis presents differently than one who has had two psychotic manias.

This baseline belongs in the treatment plan and should be updated when clinically significant changes occur, such as a first manic episode after years of bipolar II diagnosis, or the emergence of rapid cycling for the first time.

Documenting Mood Episodes: The Core Tracking Elements

When a client is in or recovering from an identifiable mood episode, the session note should capture a consistent set of clinical data. Using the same structure across notes makes longitudinal comparison meaningful.

Episode Identification and Status

Name the current episode type explicitly. Options include: manic episode, hypomanic episode, major depressive episode (MDE), mixed features specifier (for episodes with features of the opposite polarity), euthymia (absence of significant mood symptoms), or a period of subclinical fluctuation below episode threshold.

Do not document "mood lability" and leave it at that. If a client is currently hypomanic, write that. If they are coming out of a depressive episode with residual symptoms, write that. The specificity is clinically necessary and protects you if the chart is ever reviewed.

Example note language:

"Client presents in a subsiding hypomanic episode, now in day 11 of elevated mood. Sleep reduced to approximately 4 hours nightly (down from 3 hours at peak one week ago). Speech remains pressured but less so than last session. Goal-directed activity elevated. Client denied grandiosity today, endorsed irritability when questioned about medication adherence."

Duration and Trajectory

Document how long the current episode has been active, how severe it was at its peak, and whether it is escalating, plateau, or subsiding. This gives the chart a temporal structure that a single-session note cannot provide on its own.

A simple longitudinal tracking table embedded in the treatment plan or quarterly reviews can capture this efficiently:

This table is not a substitute for narrative notes, but it creates a visual episode map that is invaluable for identifying patterns and communicating with collaborating providers.

Functional Impairment

Documenting that a client is depressed is not the same as documenting the impact of the depression. Insurers, supervisors, and future clinicians need to understand what the mood episode is doing to this person's life.

Domains to document include:

• Occupational functioning: missed work, decreased productivity, conflict with colleagues
• Social and relational functioning: withdrawal, increased interpersonal conflict, relationship strain
• Self-care: changes in hygiene, nutrition, activity level
• Financial functioning: impulsive spending during hypomania/mania, inability to manage finances during depression
• Parenting or caregiving responsibilities when applicable

A fictional example: Catalina, a 34-year-old attorney with bipolar I, presented in week three of a manic episode. Her note documented: "Client reports billing 80+ hours last week, sleeping 3-4 hours nightly, initiating multiple new client acquisitions simultaneously. Reports 'never felt more focused' but acknowledged creditors calling regarding delayed payments she denied making. Spouse called to report concerns about financial decisions and sexual behavior changes."

That level of functional documentation is what distinguishes a comprehensive bipolar note from a surface-level mood check.

Documenting Mixed States and Rapid Cycling

Mixed features are among the most clinically complex presentations in bipolar disorder, and among the most under-documented. A client can present with features of both a manic and depressive episode simultaneously: elevated energy with profound hopelessness, racing thoughts with low motivation, increased goal-directed activity with persistent suicidal ideation. The DSM-5-TR uses a "with mixed features" specifier rather than a separate episode category.

Document mixed states by naming both polarities present and noting the combination. Do not default to documenting whichever polarity is more prominent and ignoring the other. The co-occurring opposite-polarity features are often what elevate the safety risk.

Example: "Client presents in a major depressive episode with mixed features. Notable hypomanic features present: decreased need for sleep (averaging 4-5 hours), increased talkativeness, and elevated goal-directed activity this week. Depressive features concurrent: hopelessness, anhedonia, recurrent passive suicidal ideation without plan. Mixed state documented given simultaneous presence of both polarity features. Risk assessment updated given that mixed presentations carry elevated suicide risk relative to purely depressive episodes."

For clients with rapid cycling, the documentation challenge is tracking how many episodes have occurred within the measurement period and whether episode frequency is changing. Document the episode count explicitly in quarterly treatment plan reviews: "Client has experienced four distinct mood episodes in the past twelve months (two hypomanic, two depressive), meeting criteria for rapid cycling specifier."

Safety Assessment During Manic and Hypomanic Episodes

Safety documentation in bipolar disorder is not only about suicidal ideation during depressive episodes, though that is critical. It also involves specific risk considerations during manic and hypomanic states that clinicians sometimes underweight.

During elevated mood states, document:

• Insight into current state. A client who lacks insight into their own hypomania is at higher behavioral risk than one who recognizes it. Note directly whether the client endorses or denies that their current mood is elevated, and what evidence supports the clinical judgment.
• Behavioral risk. Reckless driving, substance use, financial decisions, sexual behavior, and medication discontinuation are the specific risks to address. Do not document a manic episode without at least screening for these and recording the findings.
• Medication adherence. Clients often discontinue mood stabilizers during hypomanic states because they prefer how the elevation feels. This is both a safety concern and a treatment adherence issue. Document whether it was discussed and the client's response.
• Safety plan status. If the client has a crisis safety plan, note whether it was reviewed and whether any updates were made given the current episode state.

During depressive and mixed states, standard suicide risk assessment applies, with some bipolar-specific additions:

• The presence of mixed features, as noted above, elevates risk.
• Hopelessness is a stronger predictor of suicide risk in bipolar disorder than in unipolar depression. Document it specifically when present.
• Previous suicide attempts in the context of mood episodes should be referenced in the longitudinal record, not just the intake.
• Access to means should be assessed and documented, particularly during moderate to severe depressive or mixed episodes.

A fictional example of adequate safety documentation: "Marcus, 41 years old, bipolar I, currently in a major depressive episode with mixed features. PHQ-9 score: 19. C-SSRS: passive SI present ('I wouldn't mind not waking up'), no plan or intent. History of one prior attempt during a mixed episode six years ago. Current protective factors: active engagement in treatment, spouse present in home, no firearms in home (confirmed with client and confirmed via spouse contact in November). Safety plan reviewed, no changes requested. Plan to increase session frequency to twice weekly given elevated risk."

Documenting Medication Changes and Response

Therapists treating clients on psychiatric medications are not prescribers, but they are part of the clinical picture. Session notes should document what the client reports about their medications, including adherence, perceived effects, and side effect burden, even if the therapist is not the one prescribing.

When a prescriber changes a medication, the change should appear in the therapist's notes not just as a factual update but in clinical context: why it matters for the current treatment trajectory, what the client's response to the change is, and whether any new behavioral or mood effects are being monitored.

For prescribers, documentation of medication changes should include:

• Clinical rationale. What symptoms, rating scale scores, or functional observations drove the change?
• Medication being changed. Name, dose, and the change being made (e.g., "Lithium carbonate 900 mg daily increased to 1200 mg daily due to subtherapeutic lithium level at 0.6 mEq/L and persistent depressive symptoms").
• Target symptoms. What are you expecting this change to address?
• Monitoring plan. What labs, symptoms, or rating scale improvements will confirm response?
• Informed consent documentation. Was the client informed of the change and its rationale? For medications with significant side effect profiles or monitoring requirements (lithium, valproate, atypical antipsychotics), note that risks, benefits, and alternatives were discussed.

Common medications in bipolar treatment that require specific documentation considerations:

• Lithium carbonate: Requires serum level monitoring. Document levels with dates. Therapeutic range for acute mania differs from maintenance (0.8-1.2 mEq/L acute vs. 0.6-0.8 mEq/L maintenance). Document which target range applies to this client.
• Valproic acid (valproate): Serum levels, liver function, complete blood count, and teratogenic risk counseling in patients of childbearing capacity.
• Lamotrigine: Titration schedule is critical for Stevens-Johnson syndrome risk. Document each dose step and any dermatological symptoms.
• Atypical antipsychotics: Metabolic monitoring (weight, waist circumference, fasting glucose, lipid panel) and Abnormal Involuntary Movement Scale (AIMS) screening for tardive dyskinesia if used long-term.

Documenting Psychoeducation

Psychoeducation is a first-line intervention in bipolar disorder treatment. It is not just context-setting or rapport-building. Research consistently shows that psychoeducation about mood disorder reduces relapse rates, improves medication adherence, and supports clients in self-monitoring their own early warning signs.

Because psychoeducation is a billable therapeutic intervention, it should be documented as one. A note that says "discussed bipolar disorder with client" is not sufficient. Document:

• What specific content was covered (episode recognition, prodromal warning signs, sleep as a mood regulator, medication rationale, relapse triggers)
• What format was used (handout provided, verbal discussion, workbook exercise, psychoeducation group)
• The client's response, level of engagement, and any questions or pushback
• Any connection made between psychoeducation content and the client's current clinical presentation

A fictional example: "Session focused on psychoeducation regarding the role of sleep disruption as a prodromal indicator for hypomanic episodes in this client's specific illness pattern. Reviewed client's episode history together, identifying that the last three hypomanic episodes each followed a period of three or more nights of reduced sleep. Client made direct connection: 'So when I stop sleeping, that might not be a symptom. It might be the warning.' Handout on early warning sign monitoring provided. Agreed to track sleep nightly using a mood chart between sessions."

Psychoeducation around the distinction between bipolar I, bipolar II, and cyclothymia is also worth documenting when relevant, particularly for clients who have received different diagnoses over their treatment history or who are adjusting to a recent reclassification. The client's understanding of their own diagnosis is clinically significant and should appear in the chart.

Documenting Collaborative Care with Psychiatrists and Prescribers

Most clients receiving psychotherapy for bipolar disorder are also seeing a prescriber. The quality of care depends partly on whether the therapist and prescriber are working from a shared clinical picture. Documentation plays a critical role in making that coordination real rather than nominal.

When a therapist coordinates with a prescriber, the following should appear in the record:

• Date and method of contact (phone call, secure message, shared EHR note, written communication)
• Clinical information shared (current episode status, safety concerns, medication adherence as reported to therapist, functional observations)
• Information received from prescriber (medication changes, lab results, hospitalization risk assessment, prescriber's current clinical impression)
• Any agreed-upon care plan elements arising from the coordination

Do not document coordination generically. "Communicated with prescriber" is not a clinical note. Document what was communicated and why it was clinically significant.

A fictional example: "Consulted with Dr. Adeleke (psychiatry) via secure message on April 14. Reported that Beatriz has disclosed medication discontinuation (stopped lithium three weeks ago) and is showing behavioral signs consistent with emerging mania (decreased sleep, increased activity, elevated mood with irritability). Dr. Adeleke adjusted her next appointment from six weeks out to this Friday and requested that I follow up with Beatriz regarding medication restart. Communicated recommendation to client this session. Client agreed to resume lithium and confirmed appointment with Dr. Adeleke."

Authorization and consent for coordination should be documented clearly, typically in the intake paperwork or a separate release of information. Note the scope of the release: what providers are covered, what information can be shared, and the expiration or renewal date.

Distinguishing Bipolar I, Bipolar II, and Cyclothymia in Your Notes

The distinctions between subtypes matter clinically and legally. A misclassified diagnosis in a chart can affect insurance coverage, disability determinations, and how future providers approach treatment.

In ongoing notes, subtype-specific documentation practices include:

Bipolar I: Every manic episode should be documented with sufficient detail to establish that it met the DSM-5-TR threshold for mania: elevated or irritable mood, increased goal-directed activity or energy, and at least three additional criterion symptoms (grandiosity, decreased need for sleep, pressured speech, flight of ideas, distractibility, increased goal-directed activity, or reckless behavior) present for at least seven days or requiring hospitalization. Duration and severity should be explicit.

Bipolar II: The documentation challenge with bipolar II is capturing the hypomanic episode carefully enough to be distinguishable from normal mood elevation. The hypomanic episode must represent a clear change from baseline, must be observable by others, must last at least four days, and must not be severe enough to impair functioning or require hospitalization. If it does, it is mania, not hypomania, and the diagnosis may need to be reconsidered. Document what changed from baseline, who observed it, and how long it lasted.

Cyclothymia: Cyclothymia documentation requires demonstrating the two-year duration of subsyndromal fluctuation, the absence of any full manic, hypomanic, or depressive episodes during that period, and the persistence of symptoms that cause distress or functional impairment. A note that treats a cyclothymia client's mood fluctuations as casual should explicitly note why the fluctuations remain below full episode threshold.

Any time the clinical picture suggests a diagnostic reclassification (for example, a bipolar II client who experiences a first full manic episode, which reclassifies them to bipolar I), document the clinical basis for the reconsideration, consult the prescriber, and update the diagnostic formulation in the treatment plan.

Note Formats for Bipolar Disorder Treatment

DAP format (Data, Assessment, Plan) and SOAP format both work well for bipolar disorder session notes. The key is building bipolar-specific content into each section rather than using a generic template.

For a DAP note, a useful bipolar-specific structure looks like:

Data: Current episode status, duration, severity rating, key behavioral observations, rating scale scores (YMRS, PHQ-9, Mood Disorder Questionnaire (MDQ) if used), functional observations, medication adherence report, safety screen findings.

Assessment: Clinical interpretation of current episode type, trajectory (escalating, plateau, or subsiding), functional impact level, risk formulation with specific risk factors named, insight and protective factors, progress toward treatment plan goals.

Plan: Specific interventions this session (psychoeducation topic, cognitive restructuring, behavioral activation, safety planning update, medication coordination), plan for next session, any coordination actions taken or planned, frequency change if indicated.

Tools like NotuDocs, which build notes from structured templates you define, can help therapists maintain consistent bipolar-specific fields across sessions without reconstructing the format from scratch each time.

Common Documentation Mistakes in Bipolar Disorder Treatment

Using "mood swings" as a clinical descriptor. This is colloquial language that does not communicate episode type, duration, severity, or trajectory. Avoid it in clinical notes.

Failing to document insight. Whether the client recognizes their current episode state is clinically significant. It affects treatment engagement, medication adherence, and risk.

Treating euthymic periods as uneventful. A session during a euthymic period is an opportunity for relapse prevention work, psychoeducation, and strengthening the client's early warning sign recognition. Document what that work looked like.

Generic safety screening during mania. A standard depression-focused safety screen is not sufficient during manic or mixed episodes. Document behavioral risk, insight, and medication adherence as part of every safety screen in elevated mood states.

Missing the mixed features. If a client has features of both depression and hypomania/mania simultaneously, document both. A note that only captures the more visible polarity misses the clinical picture and potentially underestimates risk.

Not updating the episode history. The longitudinal episode record should be a living document, not a fixed artifact from intake. Update it when new episodes occur, when the illness course shifts, or when a prior episode is recalled and reported.

Documentation Checklist for Bipolar Disorder Treatment

Initial Assessment and Treatment Plan

• Diagnosis subtype documented with clinical basis (bipolar I, II, or cyclothymia)
• Episode history: number, type, duration, severity, precipitants
• Prior hospitalization history recorded
• Cycling pattern and frequency documented
• Baseline functional status established
• Mood monitoring plan initiated (mood chart, rating scales)
• Releases of information signed for prescriber coordination

Every Session Note

• Current episode status named explicitly (euthymic, hypomanic, manic, depressive, mixed features)
• Episode duration and trajectory documented
• Functional impairment level assessed and documented
• Rating scale administered or reason for omission noted
• Medication adherence and response documented (client report)
• Safety screen completed with findings documented: suicidal ideation, behavioral risks during elevated states, insight into current episode
• Psychoeducation documented as a clinical intervention when provided
• Coordination with prescriber documented if contact occurred

Manic and Hypomanic Episodes (Additional)

• Insight into current elevated state documented
• Behavioral risk screen: driving, finances, substance use, sexual behavior, medication adherence
• Safety plan reviewed and updated if indicated
• Prescriber contacted or notification plan documented

Mixed Features and Rapid Cycling

• Both polarity features documented explicitly
• Elevated risk acknowledged in risk formulation
• Episode count updated in treatment plan for rapid cycling clients

Medication Changes and Collaborative Care

• Medication change documented with clinical rationale, target symptoms, and monitoring plan
• Prescriber coordination documented with date, method, content, and outcome
• Informed consent for medication changes documented (prescriber records)
• Lab monitoring results noted when available and clinically relevant

Diagnostic Updates

• Any reconsideration of subtype documented with clinical basis
• Treatment plan updated when episode history shifts significantly
• Prescriber notified of any diagnostic changes or reconsiderations